Article info
PDFCurrent controversy
Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines
- Correspondence to Dr Nir Eyal, Center for Population-Level Bioethics, Rutgers University, New Brunswick, NJ 08901, USA; neyal{at}cplb.rutgers.edu
Citation
Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines
Publication history
- Received May 25, 2020
- Revised June 15, 2020
- Accepted June 25, 2020
- First published July 13, 2020.
Online issue publication
November 27, 2020
Article Versions
- Previous version (27 November 2020).
- Previous version (27 November 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Other content recommended for you
- Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia
- Will vaccination refusal prolong the war on SARS-CoV-2?
- EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update
- Assessing the burden of COVID-19 in developing countries: systematic review, meta-analysis and public policy implications
- 2021 Southern Medical Research Conference
- Representative estimates of COVID-19 infection fatality rates from four locations in India: cross-sectional study
- Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study
- COVID-19 and the heart: what we have learnt so far
- Epidemiological trends in COVID-19 pandemic: prospective critical appraisal of observations from six countries in Europe and the USA
- Cohort Profile:The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE)